Dorling and his team used a panel of 34 putative susceptibility genes, including PIK3CA, and performed sequencing of 60,466 women with breast cancer and 53,461 control cases, looking for protein-truncating variants and rare missense variants in the 34 genes. Here, PIK3CA is linked to breast carcinoma.